AF
CAI

Allworth Financial’s Caris Life Sciences CAI Stock Holding History

Allworth Financial’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.51K Buy
253
+194
+329% +$3.47K ﹤0.01% 4180
2026
Q1 		$1.05K Buy
59
+57
+2,850% +$1.25K ﹤0.01% 4558
2025
Q4 		$54 Buy
+2
New +$56 ﹤0.01% 4838

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allworth Financial's CAI Position: Q2 2026 in Review

Allworth Financial increased its Caris Life Sciences (CAI) stake by 329% in Q2 2026, buying an estimated $3.47K and bringing the position to 253 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4180.

Allworth Financial first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Allworth Financial held 253 shares of Caris Life Sciences worth $4.51K as of Q2 2026.
  • Allworth Financial bought 194 Caris Life Sciences shares in Q2 2026, an estimated $3.47K.
  • Caris Life Sciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4180 holding.
  • Allworth Financial first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.